logo logo
  • 核心技術
  • 產品介紹
  • 知識專區
  • 新聞中心
  • 合作單位
  • 關於日祥
中 | EN
新聞中心
| NEWS |
  • 全部
  • 最新消息
  • 活動快訊
  • 最新消息
    123檳榔防制日 日祥同響應
    Areca Prevention Day 3rd Dec 2022
    2022.11.23
  • 最新消息
    Oral-M®證實可區分口腔扁平苔蘚與上皮細胞變異
    New publication shows that Oral-M® can distinguish oral lichen planus from oral potentially malignant disorder with true dysplastic features and OSCC
    2022.01.28
  • 最新消息
    Review invitation, published in Diagnostics, on the current perspective in the diagnostics development for oral cancer
    2021.08.02
  • 最新消息
    Good prognosis ability of Oral-M® in patients with oral precancerous lesion
    2021.07.01
  • 最新消息
    New published Taiwan-based evidence in Gynecologic Oncology, that Cervi-M® serves as triage method to high risk HPV positive women in cervical cancer screening
    2021.04.01
  • 最新消息
    恭賀:日祥獲得藥物科技研究發展獎
    iStat Biomedical recognized at the Pharmaceutical Technology Research & Development Award
    2016.12.14
  • 最新消息
    恭賀:衛生福利部核准日祥PAX1甲基化核酸分子檢測套組
    iStat Biomedical announces the gain of market approval of in vitro diagnostic, EpiGene PAX1 DNA Methylation Detection Kit, by the Taiwan FDA
    2016.10.27
  • 最新消息
    恭賀:日祥共五項產品獲得CE認證
    iStat Biomedical announces CE market approval of five IVDs
    2016.08.29
  • 最新消息
    子宮頸癌之新型生物標誌:PAX1基因
    iStat Biomedical shows potential methylation marker for cervical cancer screening
    2014.06.19
1
2
日祥生命科學股份有限公司
22102 新北市汐止區新台五路一段96號18樓 service@istatbio.com +886-2-2696-3518
© 2022 EPIGENE All rights reserved. |
Design by M.A.K. Design
go top